On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia

Blood. 1995 Oct 15;86(8):3264-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers, Tumor
  • Cell Differentiation / drug effects
  • Gene Rearrangement
  • Humans
  • Immunologic Factors / pharmacology*
  • Immunologic Factors / therapeutic use
  • Leukemia, Promyelocytic, Acute / pathology
  • Leukemia, Promyelocytic, Acute / therapy*
  • Neoplasm Proteins / drug effects
  • Neoplasm Proteins / genetics
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / pathology
  • Receptors, Retinoic Acid / drug effects
  • Receptors, Retinoic Acid / genetics
  • Retinoic Acid Receptor alpha
  • Tretinoin / pharmacology*
  • Tretinoin / therapeutic use

Substances

  • Biomarkers, Tumor
  • Immunologic Factors
  • Neoplasm Proteins
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Tretinoin